Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-17

Clinical Trial Update: Change in Ocular Perfusion After Intravitreal Anti-VEGF in Patients with Age-related Maculopathy or Diabetic Macula Edema

View source ↗

Summary

A completed clinical trial reports a change in ocular perfusion after intravitreal anti-VEGF therapy in patients with age-related macular degeneration or diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravitreal anti-VEGF therapy (VEGF inhibitor)

Snippet

Sponsor: Augenabteilung Allgemeines Krankenhaus Linz | Conditions: Age Related Macular Degeneration, Diabetic Macular Edema | Status: COMPLETED